Using actively fine-tuned machine-learning interatomic potentials with experimental validation, the authors report that cation disorder improves lithium-path connectivity but broadens site energies, suppressing diffusion in disordered-rocksalt cathodes. They develop an energy-adjusted percolation descriptor and a Li–Mn–Ti–O design map. This is a composition-specific transport result; the review does not assign individual capacity figures to modeled or measured material states.
Technology: Actively fine-tuned machine-learning interatomic potentials
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Publisher abstract describes atomistic analysis combined with experimental validation within the discovery study.
- Still unknown: Review scope was the publisher abstract and metadata; full experimental details and capacity attribution were not assessed. Article-in-press text may change.
- AI role: Learned atomistic potentials enabled analysis of lithium connectivity and site-energy distributions.
Evidence sources: https://www.nature.com/articles/s41467-026-79420-w
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
A literature-mining workflow using GPT-4o extracted values from 465 papers; a graph-neural-network-based pipeline screened 69,920 oxyhalide structures. Ab initio molecular-dynamics simulations for LiMoOBr₄ report a lithium content of 2.28 mol kg⁻¹, a 300 K extrapolated ionic conductivity of 13.53 mS cm⁻¹ and a 0.22 eV activation energy. The reported material properties are computational predictions, not experimental measurements.
Technology: GPT-4o literature extraction; diffusion-model and graph-neural-network screening
Family GPT-4: profile · models page
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: The paper reports computational screening of 69,920 oxyhalides and AIMD estimates for LiMoOBr₄: 2.28 mol kg⁻¹ lithium, 13.53 mS cm⁻¹ ionic conductivity extrapolated to 300 K and 0.22 eV activation energy.
- Still unknown: The checked abstract/index does not establish experimental synthesis or measured conductivity; predictions should not be described as experimentally confirmed. Full methods were not accessible in the current check.
- AI role: GPT-4o was used to extract literature data from 465 papers; a learned graph-neural-network screening pipeline contributed to nomination of LiMoOBr₄ for computational validation.
Evidence sources: https://www.sciencedirect.com/science/article/pii/S3051383926001210
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 17 Nov 2026. Review scope: Primary publisher indexed abstract/highlights and saved publisher affiliation metadata; direct publisher page returned 403. University announcement checked only as corroboration, not as primary evidence..
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
After experimentally screening activity-enhancing single mutants of LdTPS5, the researchers used PIFS-PLM, a few-shot model that selects features from protein-language-model embeddings using active-site and conserved-residue information, to propose mutation combinations. All 10 tested model-predicted combinations were active; nine produced more than 100 mg/L bicyclogermacrene in yeast, and the top variant produced 213.59 mg/L versus 2.93 mg/L for wild type (about 73-fold higher yield). A related selectivity-optimized combination increased bicyclogermacrene selectivity by 15%.
Technology: PIFS-PLM (Physics-Inspired Feature Selection of Protein Language Models), using ESM-2 embeddings with a few-shot mutation-combination classifier
Family ESM / ESMFold: profile · models page
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: After experimentally screening activity-enhancing single mutants of LdTPS5, the researchers used PIFS-PLM, a few-shot model that selects features from protein-language-model embeddings using active-site and conserved-residue information, to propose mutation combinations.
- Still unknown: The 73-fold result is product yield in the reported yeast system, reflecting effects of enzyme activity and expression; it is not a 73-fold increase in catalytic rate. The selectivity improvement was 15%. The model relies on a defined active site/conserved-site set and a small, enzyme-specific experimental dataset. Product profiles differed between cell-free extracts and yeast; these results do not establish universal performance across enzymes or production settings.
- AI role: After single substitutions were screened and activity-enhancing mutations experimentally validated, PIFS-PLM used 60–100 measured combinations to learn from selected ESM-2 features at active-site and conserved residues and predict beneficial combinations. Ten predicted LdTPS5 variants were tested; all were active, and the top variants substantially increased measured yeast product yield. The model also guided a selectivity optimization test. Initial single-mutation nomination used MM/GBSA or sequence conservation analysis, separate from PIFS-PLM combinatorial predictions.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13502649/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
Parallelized hybrid-space Bayesian optimization prioritized metal/ligand carriers and conditions for enzyme immobilization. The primary abstract reports activity recovery of 100% for glucose oxidase, 90% for catalase and 79% for Candida antarctica lipase B across the demonstrated workflow. These are enzyme-specific assay outcomes, not discovery of new enzymes or proof of industrial stability.
Technology: Parallelized hybrid-space Bayesian optimization (PHBO)
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: The primary source reports the study-specific measured result summarized here.
- Still unknown: Independent replication and clinical or industrial efficacy are not established.
- AI role: The optimizer proposes carrier compositions and experimental conditions, then experimental activity feedback informs later proposals.
Evidence sources: https://www.nature.com/articles/s41467-026-70251-3
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 16 Nov 2026. Review scope: Primary source indexed full text or abstract and publication metadata reviewed; scope stated in source_checks..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
The January 2026 Science abstract reports DrugCLIP screening roughly 10,000 human proteins against 500 million compounds. Experimental hits included 15% for the norepinephrine transporter, with structures of two inhibitor complexes, and 17.5% for TRIP12 using AlphaFold2 structures. Most database results remain computational. The work also has a bioRxiv preprint first indexed in September 2024.
Technology: DrugCLIP (deep contrastive learning)
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Biochemical hit testing and structures of two NET inhibitor complexes.
- Still unknown: Not assessed: full assay denominators, uncertainty and genome-wide experimental coverage.
- AI role: Contrastive learning ranked protein-compound pairs.
Evidence sources: https://pubmed.ncbi.nlm.nih.gov/41505557/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
The January 2026 Nature Biotechnology abstract reports 40 small-molecule hits across ten disease-associated RNA targets, with nanomolar-to-micromolar binding. One predicted compound reduced MYC expression, inhibited proliferation and promoted apoptosis in three cancer cell lines. SMRTnet combines language models with convolutional and graph attention networks, using RNA secondary structure. These are laboratory results.
Technology: SMRTnet (language-model-based)
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: RNA-binding assays and cancer-cell experiments.
- Still unknown: Not assessed: full-paper validation rates and therapeutic performance.
- AI role: Multimodal deep learning predicted small molecule-RNA interactions.
Evidence sources: https://pubmed.ncbi.nlm.nih.gov/41482542/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
An information-flow analysis of daily observations found statistically significant local surface-soil-moisture effects on precipitation over about 15.7% of global land (60°S–60°N) in the boreal warm season, with eight regional hotspots. Sensible-heat mediation dominated most hotspots, while evapotranspiration mediation dominated two African hotspots; remote moisture availability and boundary-layer-height variability helped explain regional differences. Only four of 16 assessed CMIP6 models reproduced the ERA5-derived relationship between soil-moisture variability and causal coupling.
Technology: Neural-network-inversion satellite soil-moisture product (NNSm), analyzed with Liang–Kleeman information-flow causal inference
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: An information-flow analysis of daily observations found statistically significant local surface-soil-moisture effects on precipitation over about 15.7% of global land (60°S–60°N) in the boreal warm season, with eight regional hotspots.
- Still unknown: The mapped effect is local surface-soil-moisture-to-precipitation information flow, statistically significant at the authors' p<0.1 threshold over about 15.7% of land; the analysis does not imply local soil moisture causes rainfall everywhere or exclude remote/upwind effects. The AI contribution is the neural-network-derived satellite soil-moisture product; the causal analysis is not itself an AI model. The spatial pattern was broadly checked with ERA5, while pathway attribution depends on ERA5-reanalysis variables and the assumptions/limitations of information-flow causal inference. Results concern boreal warm seasons and the analyzed 2003–2020 satellite period (ERA5 cross-check spans 1979–2021).
- AI role: The study's long-term daily satellite soil-moisture series was generated with a neural-network inversion algorithm, extending the observed record used to map global coupling. Researchers applied information-flow analysis to this AI-derived product and precipitation observations, then cross-checked the main spatial pattern using independent ERA5 reanalysis. AI provided the satellite soil-moisture input for a concrete global climate result; the causal-inference method itself is an information-theoretic statistical technique, not a learned model.
Evidence sources: https://www.nature.com/articles/s41467-025-63999-7
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 42 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
A backpropagation neural network fitted composition/activity and deactivation data and suggested a Ru:Ti:Mn ratio of 0.26:0.26:0.48. The synthesized electrode had measured composition near 0.24:0.28:0.48 and reported 165.2 mV overpotential at 10 mA cm−2 in the acidic assay. Model optimum and measured composition are distinct; reported long-duration tests apply only under the study’s specific conditions.
Technology: Backpropagation neural network
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Preprint
- Test type: direct test
- Tested: Research Square v1 reports measured Ru/Ti/Mn electrode and acidic OER result.
- Still unknown: Exact prior composition overlap and whether candidate was included in training data remain open.
- AI role: Neural network fit experimental composition/activity/durability data to suggest a candidate composition, which was synthesized and tested.
Evidence sources: https://doi.org/10.21203/rs.3.rs-5208867/v1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 16 Nov 2026. Review scope: Primary source checked for identity, publication date, AI workflow and the bounded experimental result stated..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
Progeni combines a probabilistic knowledge graph with graph neural networks to rank disease-associated molecular targets. The authors selected six candidates lacking literature support and reported that knockdown of HSP90AB1 and MME reduced proliferation in a murine melanoma line, while knockdown of ADCY5, ADRA2A and EEF2 reduced proliferation in a murine colorectal-cancer line.
Technology: Progeni probabilistic knowledge graph and graph neural network
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: The authors selected six candidates lacking literature support and reported that knockdown of HSP90AB1 and MME reduced proliferation in a murine melanoma line, while knockdown of ADCY5, ADRA2A and EEF2 reduced proliferation in a murine colorectal-cancer line.
- Still unknown: The functional validations were in B16F10 and MC38 murine cell lines, not human tumor samples or clinical settings. The paper evaluates a model and validates selected candidates; it does not establish these as clinically effective therapeutic targets.
- AI role: The graph neural network ranked new target hypotheses from heterogeneous biological networks and literature co-occurrence evidence. Researchers then tested selected predictions by shRNA knockdown in representative murine cancer cell lines.
Evidence sources: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1011945
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: at percentile 81 of works of the same type, year and subfield (OpenAlex work metrics, 11 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
In a multicenter study of 702 participants, targeted plasma metabolomics and machine learning produced a 10-metabolite gastric-cancer diagnostic model and separate 28-metabolite survival-risk model. The diagnostic model was evaluated in an independent 95-person cohort (AUROC 0.920; sensitivity 0.905, specificity 0.75) and detected stage IA disease with AUROC 0.909. Among 181 patients followed for a median 40 months, the prognostic model achieved test-set concordance index 0.83. Succinate, uridine and lactate were among diagnostic features.
Technology: LASSO, random forest and random survival forest
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: The diagnostic model was evaluated in an independent 95-person cohort (AUROC 0.920; sensitivity 0.905, specificity 0.75) and detected stage IA disease with AUROC 0.909.
- Still unknown: Case-control cohorts do not establish population screening performance. External diagnostic test n=95; prognosis cohort median follow-up 40 months with right-censored outcomes. The paper says direct clinical use is premature and requires quality-control samples. Associations are not causal and no model-guided benefit was tested.
- AI role: LASSO selected ten plasma metabolites for a diagnostic model evaluated in internal and independent external cohorts. Random survival forest selected a 28-metabolite prognostic panel, evaluated in a held-out patient set.
Evidence sources: https://www.nature.com/articles/s41467-024-46043-y.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 289 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
Learned architecture models and finite-element simulations guided fabrication of scaffold subunits. A larger scaffold assembled through human adaptation of the learned structures showed about 20% greater load-bearing capacity than the uniform comparator. This is a mechanical bench-test result, not evidence of implantation, bone healing or clinical benefit.
Technology: GAD-MALL autoencoder and convolutional active learning
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Printed structures received mechanical tests.
- Still unknown: Independent replication and in-vivo outcomes were not established.
- AI role: GAD-MALL autoencoder and convolutional active learning supported the stated study; experimental and interpretive work remained with researchers.
Evidence sources: https://www.nature.com/articles/s41467-023-42415-y · https://pure.mpg.de/pubman/item/item_3643037_1/component/file_3643048/s41467-023-42415-y.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 16 Nov 2026. Review scope: Indexed primary publisher affiliations, date and selected design Results; indexed institutional publisher PDF mechanical comparison. Supplements not reviewed..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.